Concepedia

Craig M. Brackett

CM

Statistics

Publications

11

Citations

534

H-Index

11

Active since

2011

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Cleveland BioLabs (United States)

Gamalei Institute of Epidemiology and Microbiology

Buffalo BioLabs

Sanford Burnham Prebys Medical Discovery Institute

Craig M. Brackett is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, tumor immunity, and immunotherapy.

ORCID

Top concepts

Publications per year

2011–2023

11

Publications

11

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist

Lyudmila G. Burdelya, Craig M. Brackett, Bojidar Kojouharov et al. · Proceedings of the National Academy of Sciences · 2013 · 120 citations · Full text

Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8 <sup>+</sup> T-cell axis

Craig M. Brackett, Bojidar Kojouharov, Jean Veith et al. · Proceedings of the National Academy of Sciences · 2016 · 95 citations

IL-17 Promotes Neutrophil Entry into Tumor-Draining Lymph Nodes following Induction of Sterile Inflammation

Craig M. Brackett, Jason B. Muhitch, Sharon S. Evans et al. · The Journal of Immunology · 2013 · 71 citations · Full text

, , +19

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism

Hua Yang, Craig M. Brackett, Vanessa Morales-Tirado et al. · Oncotarget · 2015 · 46 citations · Full text

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy

Vadim Mett, Elena A. Komarova, Kristopher M. Greene et al. · Oncogene · 2017 · 44 citations · Full text

, , +26

1–5 of 11